Management lifted its profit outlook, and investors have more than quadrupled that bet. The question now is what they’re really paying for.

When Eli Lilly’s (LLY) management told Wall Street on Apr 30, 2026, that they saw a clearer path to higher profits for 2026, the market sprinted in response. Since that day, the stock has been up meaningfully, tacking on a massive 26% gain. That’s a handsome reward for a company that raised its full-year EPS guidance by 6%.

A quick calculation reveals a clear disparity. A 6% bump in the profit forecast sparked a rally more than four times as large. Why such an outsized reaction to a simple guidance beat? The market is telling you it believes this is the start of something much bigger….